Marc Dalod

24PUBLICATIONS
148CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCriminological theories
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 27, 2026
TSLP promotes GATA3-expressing effector regulatory T cells via DC2 derived from transitional DCs.

Marine Guivarch, Pierre Meyer, Antoine Braud

|Dec 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity.

Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely

|Nov 25, 2025
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection.

Elena Hernández-García, Miguel Galán, Sofía C Khouili

|Nov 19, 2025
Ontogenetic Diversification of Type 2 Conventional Dendritic Cells in the Bone Marrow: A Central Logic for Peripheral Immunity.

Robert W Baber, Miguel  Magalhães-Patrício, Maria V Pires

Pageof 4